CGNX
Cognex CorpPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $72M | Q1 2026 | — |
| Adjusted EBITDA margin non-GAAP | 26.9% | Q1 2026 | — |
| Adjusted EPS (Diluted) non-GAAP | $0.34 | Q1 2026 | — |
| Adjusted gross margin non-GAAP | 71.8% | Q1 2026 | — |
| Adjusted operating margin non-GAAP | 25.2% | Q1 2026 | — |
| FCF conversion rate (of net income) non-GAAP | 82% | Q1 2026 | — |
| adjusted diluted EPS non-GAAP | $0.34 | Q1 2026 call | — |
| adjusted EBITDA growth non-GAAP | 100% | Q1 2026 call | — |
| adjusted EBITDA margin expansion non-GAAP | 1,010 | Q1 2026 call | — |
| adjusted EPS growth non-GAAP | 113% | Q1 2026 call | — |
| cash conversion cycle improvement | 57 | Q1 2026 call | — |
| reorganization charges | $4.8M | Q1 2026 call | — |
| trailing 12-month free cash flow | $241M | trailing 12 months Q1 2026 call | — |
| trailing 12-month free cash flow conversion rate non-GAAP | 119% | trailing 12 months Q1 2026 call | — |
| Adjusted EBITDA margin (excluding CP) non-GAAP | 20.7% | Twelve-months ended December 31, 2025 | — |
| Capital returned to shareholders | $206M | Full year 2025 | — |
| Share buybacks | $151M | Full year 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Scientific & Technical Instruments — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CGNX
this stock
Cognex Corp
|
$10.45B | +81.0% | +8.7% | 73.9 | 4.9% |
|
COHR
Coherent Corp.
|
$57.95B | +68.4% | +19.2% | 140.4 | 4.4% |
|
KEYS
Keysight Technologies, Inc.
|
$55.15B | +60.3% | +8.0% | 52.9 | 1.8% |
|
GRMN
Garmin Ltd
|
$46.65B | +19.5% | +15.1% | 27.0 | 2.2% |
|
TDY
Teledyne Technologies Inc
|
$28.62B | +22.0% | +24.1% | 31.3 | 3.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CGNX | +1.3% | +2.2% | +67.3% | -10.2% | +81.0% |
| SPY | +0.6% | +1.4% | +11.0% | +0.7% | +10.3% |
| vs SPY | +0.7% | +0.9% | +56.4% | -10.9% | +70.8% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.